Targeting Interleukin-4 Receptor Alpha by Hybrid Peptide for Novel Biliary Tract Cancer Therapy

It is known that the interleukin-4 receptor α (IL-4Rα) is highly expressed on the surface of various human solid tumors. We previously designed novel IL-4Rα-lytic hybrid peptide composed of binding peptide to IL-4Rα and cell-lytic peptide and reported that the designed IL-4Rα-lytic hybrid peptide ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Seto, Kahori, Shoda, Junichi, Horibe, Tomohisa, Warabi, Eiji, Kohno, Masayuki, Yanagawa, Toru, Bukawa, Hiroki, Nakanuma, Yasuni, Kawakami, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020457/
https://www.ncbi.nlm.nih.gov/pubmed/24868471
http://dx.doi.org/10.1155/2014/584650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020457/
https://www.ncbi.nlm.nih.gov/pubmed/24868471
http://dx.doi.org/10.1155/2014/584650

Ejemplares similares